Henry Waxman doesn’t *care* what President Obama said.

    And he wants to make sure that the pharmaceutical companies understand that, too. The House Energy Chair intends to retroactively remove what Waxman calls a ‘windfall’ involving Medicare D drug charges, and never mind what either the President or PhRMA thinks: Drug makers contend they have already worked out a 10-year, $80 billion cost-savings deal with the White House and crucial Senate gatekeepers on the | Read More »